Report Detail

Medical Devices & Consumables Global Non-Surgical Urinary Incontinence Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4696901
  • |
  • 21 May, 2026
  • |
  • Global
  • |
  • 119 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Non-Surgical Urinary Incontinence Treatment market size was valued at US$ 2304 million in 2025 and is forecast to a readjusted size of US$ 5084 million by 2032 with a CAGR of 12.1% during review period.
Non-invasive urinary incontinence treatment options are available for people who experience urinary incontinence, which is the involuntary loss of urine. These treatments may be used alone or in combination with other therapies, depending on the type and severity of the incontinence.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Non-Surgical Urinary Incontinence Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Surgical Urinary Incontinence Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Surgical Urinary Incontinence Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Surgical Urinary Incontinence Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Surgical Urinary Incontinence Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Surgical Urinary Incontinence Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Surgical Urinary Incontinence Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific Corporation, Johnson & Johnson, Cogentix Medical, Coloplast Corp, Ethicon, InControl Medical, Hollister Incorporated, Atlantic Therapeutics, ZSI Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-Surgical Urinary Incontinence Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Biofeedback
Electrical stimulation
Medications
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
Medtronic
Boston Scientific Corporation
Johnson & Johnson
Cogentix Medical
Coloplast Corp
Ethicon
InControl Medical
Hollister Incorporated
Atlantic Therapeutics
ZSI Medical
B. Braun Melsungen
Teleflex Medical
STORZ MEDICAL
Lumenis
NeoTract
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Surgical Urinary Incontinence Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-Surgical Urinary Incontinence Treatment, with price, sales quantity, revenue, and global market share of Non-Surgical Urinary Incontinence Treatment from 2021 to 2026.
Chapter 3, the Non-Surgical Urinary Incontinence Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Surgical Urinary Incontinence Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-Surgical Urinary Incontinence Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Surgical Urinary Incontinence Treatment.
Chapter 14 and 15, to describe Non-Surgical Urinary Incontinence Treatment sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Non-Surgical Urinary Incontinence Treatment Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Biofeedback
    • 1.3.3 Electrical stimulation
    • 1.3.4 Medications
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Non-Surgical Urinary Incontinence Treatment Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Non-Surgical Urinary Incontinence Treatment Market Size & Forecast
    • 1.5.1 Global Non-Surgical Urinary Incontinence Treatment Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Non-Surgical Urinary Incontinence Treatment Sales Quantity (2021-2032)
    • 1.5.3 Global Non-Surgical Urinary Incontinence Treatment Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.1.4 Medtronic Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 Boston Scientific Corporation
    • 2.2.1 Boston Scientific Corporation Details
    • 2.2.2 Boston Scientific Corporation Major Business
    • 2.2.3 Boston Scientific Corporation Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.2.4 Boston Scientific Corporation Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boston Scientific Corporation Recent Developments/Updates
  • 2.3 Johnson & Johnson
    • 2.3.1 Johnson & Johnson Details
    • 2.3.2 Johnson & Johnson Major Business
    • 2.3.3 Johnson & Johnson Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.3.4 Johnson & Johnson Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Johnson & Johnson Recent Developments/Updates
  • 2.4 Cogentix Medical
    • 2.4.1 Cogentix Medical Details
    • 2.4.2 Cogentix Medical Major Business
    • 2.4.3 Cogentix Medical Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.4.4 Cogentix Medical Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Cogentix Medical Recent Developments/Updates
  • 2.5 Coloplast Corp
    • 2.5.1 Coloplast Corp Details
    • 2.5.2 Coloplast Corp Major Business
    • 2.5.3 Coloplast Corp Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.5.4 Coloplast Corp Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Coloplast Corp Recent Developments/Updates
  • 2.6 Ethicon
    • 2.6.1 Ethicon Details
    • 2.6.2 Ethicon Major Business
    • 2.6.3 Ethicon Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.6.4 Ethicon Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ethicon Recent Developments/Updates
  • 2.7 InControl Medical
    • 2.7.1 InControl Medical Details
    • 2.7.2 InControl Medical Major Business
    • 2.7.3 InControl Medical Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.7.4 InControl Medical Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 InControl Medical Recent Developments/Updates
  • 2.8 Hollister Incorporated
    • 2.8.1 Hollister Incorporated Details
    • 2.8.2 Hollister Incorporated Major Business
    • 2.8.3 Hollister Incorporated Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.8.4 Hollister Incorporated Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Hollister Incorporated Recent Developments/Updates
  • 2.9 Atlantic Therapeutics
    • 2.9.1 Atlantic Therapeutics Details
    • 2.9.2 Atlantic Therapeutics Major Business
    • 2.9.3 Atlantic Therapeutics Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.9.4 Atlantic Therapeutics Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Atlantic Therapeutics Recent Developments/Updates
  • 2.10 ZSI Medical
    • 2.10.1 ZSI Medical Details
    • 2.10.2 ZSI Medical Major Business
    • 2.10.3 ZSI Medical Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.10.4 ZSI Medical Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 ZSI Medical Recent Developments/Updates
  • 2.11 B. Braun Melsungen
    • 2.11.1 B. Braun Melsungen Details
    • 2.11.2 B. Braun Melsungen Major Business
    • 2.11.3 B. Braun Melsungen Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.11.4 B. Braun Melsungen Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 B. Braun Melsungen Recent Developments/Updates
  • 2.12 Teleflex Medical
    • 2.12.1 Teleflex Medical Details
    • 2.12.2 Teleflex Medical Major Business
    • 2.12.3 Teleflex Medical Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.12.4 Teleflex Medical Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Teleflex Medical Recent Developments/Updates
  • 2.13 STORZ MEDICAL
    • 2.13.1 STORZ MEDICAL Details
    • 2.13.2 STORZ MEDICAL Major Business
    • 2.13.3 STORZ MEDICAL Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.13.4 STORZ MEDICAL Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 STORZ MEDICAL Recent Developments/Updates
  • 2.14 Lumenis
    • 2.14.1 Lumenis Details
    • 2.14.2 Lumenis Major Business
    • 2.14.3 Lumenis Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.14.4 Lumenis Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Lumenis Recent Developments/Updates
  • 2.15 NeoTract
    • 2.15.1 NeoTract Details
    • 2.15.2 NeoTract Major Business
    • 2.15.3 NeoTract Non-Surgical Urinary Incontinence Treatment Product and Services
    • 2.15.4 NeoTract Non-Surgical Urinary Incontinence Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 NeoTract Recent Developments/Updates

3 Competitive Environment: Non-Surgical Urinary Incontinence Treatment by Manufacturer

  • 3.1 Global Non-Surgical Urinary Incontinence Treatment Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Non-Surgical Urinary Incontinence Treatment Revenue by Manufacturer (2021-2026)
  • 3.3 Global Non-Surgical Urinary Incontinence Treatment Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Non-Surgical Urinary Incontinence Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Non-Surgical Urinary Incontinence Treatment Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Non-Surgical Urinary Incontinence Treatment Manufacturer Market Share in 2025
  • 3.5 Non-Surgical Urinary Incontinence Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 Non-Surgical Urinary Incontinence Treatment Market: Region Footprint
    • 3.5.2 Non-Surgical Urinary Incontinence Treatment Market: Company Product Type Footprint
    • 3.5.3 Non-Surgical Urinary Incontinence Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Non-Surgical Urinary Incontinence Treatment Market Size by Region
    • 4.1.1 Global Non-Surgical Urinary Incontinence Treatment Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Non-Surgical Urinary Incontinence Treatment Consumption Value by Region (2021-2032)
    • 4.1.3 Global Non-Surgical Urinary Incontinence Treatment Average Price by Region (2021-2032)
  • 4.2 North America Non-Surgical Urinary Incontinence Treatment Consumption Value (2021-2032)
  • 4.3 Europe Non-Surgical Urinary Incontinence Treatment Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Non-Surgical Urinary Incontinence Treatment Consumption Value (2021-2032)
  • 4.5 South America Non-Surgical Urinary Incontinence Treatment Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Non-Surgical Urinary Incontinence Treatment Sales Quantity by Type (2021-2032)
  • 5.2 Global Non-Surgical Urinary Incontinence Treatment Consumption Value by Type (2021-2032)
  • 5.3 Global Non-Surgical Urinary Incontinence Treatment Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Non-Surgical Urinary Incontinence Treatment Sales Quantity by Application (2021-2032)
  • 6.2 Global Non-Surgical Urinary Incontinence Treatment Consumption Value by Application (2021-2032)
  • 6.3 Global Non-Surgical Urinary Incontinence Treatment Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Non-Surgical Urinary Incontinence Treatment Sales Quantity by Type (2021-2032)
  • 7.2 North America Non-Surgical Urinary Incontinence Treatment Sales Quantity by Application (2021-2032)
  • 7.3 North America Non-Surgical Urinary Incontinence Treatment Market Size by Country
    • 7.3.1 North America Non-Surgical Urinary Incontinence Treatment Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Non-Surgical Urinary Incontinence Treatment Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Non-Surgical Urinary Incontinence Treatment Sales Quantity by Type (2021-2032)
  • 8.2 Europe Non-Surgical Urinary Incontinence Treatment Sales Quantity by Application (2021-2032)
  • 8.3 Europe Non-Surgical Urinary Incontinence Treatment Market Size by Country
    • 8.3.1 Europe Non-Surgical Urinary Incontinence Treatment Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Non-Surgical Urinary Incontinence Treatment Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Non-Surgical Urinary Incontinence Treatment Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Non-Surgical Urinary Incontinence Treatment Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Non-Surgical Urinary Incontinence Treatment Market Size by Region
    • 9.3.1 Asia-Pacific Non-Surgical Urinary Incontinence Treatment Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Non-Surgical Urinary Incontinence Treatment Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Non-Surgical Urinary Incontinence Treatment Sales Quantity by Type (2021-2032)
  • 10.2 South America Non-Surgical Urinary Incontinence Treatment Sales Quantity by Application (2021-2032)
  • 10.3 South America Non-Surgical Urinary Incontinence Treatment Market Size by Country
    • 10.3.1 South America Non-Surgical Urinary Incontinence Treatment Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Non-Surgical Urinary Incontinence Treatment Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Market Size by Country
    • 11.3.1 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Non-Surgical Urinary Incontinence Treatment Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Non-Surgical Urinary Incontinence Treatment Market Drivers
  • 12.2 Non-Surgical Urinary Incontinence Treatment Market Restraints
  • 12.3 Non-Surgical Urinary Incontinence Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Non-Surgical Urinary Incontinence Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Non-Surgical Urinary Incontinence Treatment
  • 13.3 Non-Surgical Urinary Incontinence Treatment Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Non-Surgical Urinary Incontinence Treatment Typical Distributors
  • 14.3 Non-Surgical Urinary Incontinence Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Non-Surgical Urinary Incontinence Treatment. Industry analysis & Market Report on Non-Surgical Urinary Incontinence Treatment is a syndicated market report, published as Global Non-Surgical Urinary Incontinence Treatment Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-Surgical Urinary Incontinence Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report